Equities

S.Ishimitsu & Co Ltd

2750:TYO

S.Ishimitsu & Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)787.00
  • Today's Change-3.00 / -0.38%
  • Shares traded6.00k
  • 1 Year change+6.35%
  • Beta0.6256
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

S.ISHIMITSU & CO., LTD. is primarily engaged in the sales of coffee and food products. The Company operates in three business segments. The Coffee and Beverage segment provides green coffee beans, regular coffee, instant coffee, tea, and coffee related equipment and supplies. The Food segment provides bottles and cans, wheat products, condiments, dairy products, oils and fats, liquors, processed products, fresh vegetables, vegetable cans, salted vegetables and others. The Overseas segment deals with all the items the Coffee and Beverage segment and Food segment provided. The Company imports or purchases these items and sells to food wholesalers, beverage and food manufacturers, restaurants and others, and is also involved in restaurant operation and other business through subsidiaries.

  • Revenue in JPY (TTM)61.81bn
  • Net income in JPY1.10bn
  • Incorporated1951
  • Employees482.00
  • Location
    S.Ishimitsu & Co Ltd4-40, Iwaya Minami-machi, Nada-kuKOBE-SHI 657-0856JapanJPN
  • Phone+81 788617791
  • Fax+81 788821007
  • Websitehttps://www.ishimitsu.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Maruyoshi Center Inc40.44bn59.34m3.71bn463.0062.081.244.360.091763.8763.8743,339.863,202.832.4121.8251.1487,342,700.000.47371.620.83892.7127.0327.010.19690.69590.33111.210.672910.663.34-0.1457-4.84---1.59--
Cotta Co Ltd8.91bn420.47m3.87bn96.008.760.87827.160.434839.4039.40835.36392.841.423.4526.3392,772,870.006.716.569.709.4032.0537.444.724.351.5580.120.216814.67-2.586.5442.7310.83-8.8336.85
Life Intelligent Enterprise HoldngsCoLtd14.71bn-1.79bn3.98bn179.00--0.772--0.2703-23.96-23.96196.4050.522.1812.2813.2182,175,820.00-26.54-2.71-42.40-4.3013.1018.80-12.20-0.94441.87-45.700.2822--6.244.24-2,021.68--5.63--
Hokuyu Lucky Co., Ltd.37.34bn128.66m4.04bn418.0031.390.7246.370.1082101.79101.7929,546.544,412.752.0915.9633.2389,340,800.000.72041.191.282.5628.4928.150.34450.55090.491517.170.53228.920.5105-2.03138.8023.069.850.00
Sapporo Clinical Laboratory Inc19.82bn376.27m4.10bn871.008.290.27886.720.2068117.29117.296,127.513,486.291.2024.036.7722,751,890.002.194.662.795.9730.1531.641.833.582.01338.430.156710.38-2.212.89-33.14-6.1912.5618.13
O' will Corp35.74bn853.49m5.44bn101.006.081.107.020.1522283.98283.9811,876.581,572.632.278.915.23353,852,300.005.445.0312.4510.9410.349.792.391.771.25--0.501727.141.660.253517.4110.6026.084.56
Echo Trading Co Ltd107.20bn1.18bn5.51bn323.004.620.48484.410.0514196.30196.3017,841.001,870.792.8926.194.61331,876,200.003.181.5910.615.0111.4711.691.100.51411.21220.210.130630.0510.785.79105.56--8.296.96
S.Ishimitsu & Co Ltd61.81bn1.10bn6.32bn482.005.580.51913.560.1022141.53141.537,981.201,521.861.645.075.16128,242,100.003.052.086.864.4913.3113.931.871.271.02--0.445423.095.189.9832.4920.4810.9720.11
SHINYEI KAISHA39.55bn1.35bn6.35bn467.004.630.81483.830.1606328.98328.989,664.601,870.421.553.516.5384,689,500.005.262.4910.076.2720.9220.073.401.480.6336--0.62516.860.7821-1.2274.39---28.14--
Iceco Inc37.48bn90.81m6.53bn752.0073.951.7318.680.174322.6222.629,624.28967.441.9738.236.1749,844,020.000.47851.911.394.8817.3417.830.24230.64530.9025--0.430715.3712.507.48120.867.3910.81--
Pharmarise Holdings Corp56.23bn-605.00m7.39bn1.85k--0.98411.700.1315-51.83-51.835,123.14622.952.1913.4157.2330,425,320.00-2.351.18-3.961.9315.0415.38-1.070.55990.739210.110.594851.964.681.04-205.41--6.210.00
Medical Ikkou Group Co Ltd45.12bn1.30bn8.35bn1.43k5.910.56034.020.1851347.20347.2012,003.763,662.091.4625.637.4631,527,570.004.353.116.504.5212.3010.522.972.551.42--0.394118.2417.715.0336.897.88-21.672.38
Kuze Co Ltd66.01bn2.02bn8.40bn627.004.161.173.490.1272436.20436.2014,268.241,544.872.8015.2810.02105,277,500.008.55-0.033619.80-0.08622.7321.613.06-0.01241.05231.880.375--14.19-0.4686141.3557.2312.974.56
Jason Co Ltd28.56bn510.82m8.65bn194.0016.931.3712.760.302839.8739.872,229.29491.322.468.3345.17147,221,600.004.396.487.0610.2625.7226.441.792.311.27162.200.131325.455.564.220.51686.61-1.567.63
Aseed Holdings Co Ltd24.04bn619.00m8.65bn744.0012.731.119.070.359850.3550.351,956.14577.821.2412.146.7932,313,170.003.192.836.385.5336.6936.042.581.950.6677--0.479137.959.57-3.6327.578.89-5.8611.20
Oomitsu Co Ltd72.14bn637.63m9.23bn549.0014.281.517.790.127943.4343.434,913.29409.923.1911.7611.57131,408,400.002.821.066.102.3018.9519.440.88380.32020.680278.740.565968.878.762.3179.2612.8445.288.45
Data as of Nov 15 2024. Currency figures normalised to S.Ishimitsu & Co Ltd's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.